These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 28371454)

  • 1. Tumor biology remains the main determinant of prognosis in retroperitoneal sarcomas: a 14-year single-center experience.
    Ng DWJ; Tan GHC; Chia CS; Chee SK; Quek R; Farid M; Teo MCC
    Asia Pac J Clin Oncol; 2017 Oct; 13(5):e458-e465. PubMed ID: 28371454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features.
    Abdelfatah E; Guzzetta AA; Nagarajan N; Wolfgang CL; Pawlik TM; Choti MA; Schulick R; Montgomery EA; Meyer C; Thornton K; Herman J; Terezakis S; Frassica D; Ahuja N
    J Surg Oncol; 2016 Jul; 114(1):56-64. PubMed ID: 27076350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncology outcomes in Retroperitoneal sarcomas: Prognostic factors in a Retrospective Cohort study.
    Garcia-Ortega DY; Villa-Zepeda O; Martinez-Said H; Cuellar-Hübbe M; Luna-Ortiz K
    Int J Surg; 2016 Aug; 32():45-9. PubMed ID: 27268726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival and prognostic factors of primary retroperitoneal sarcomas after surgery: a single-center experience.
    Zhao S; Zhou J; Li R; Sun L; Sun Q; Wang W; Wang D
    Langenbecks Arch Surg; 2024 Jul; 409(1):216. PubMed ID: 39008130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with surgical treatment of retroperitoneal soft tissue sarcomas at a university hospital in Thailand.
    Sriussadaporn S; Sriussadaporn S; Pak-art R; Kritayakirana K; Prichayudh S; Samorn P
    J Med Assoc Thai; 2014 Jun; 97(6):598-614. PubMed ID: 25137877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Post-relapse outcomes after primary extended resection of retroperitoneal sarcoma: A report from the Trans-Atlantic RPS Working Group.
    MacNeill AJ; Miceli R; Strauss DC; Bonvalot S; Hohenberger P; Van Coevorden F; Rutkowski P; Callegaro D; Hayes AJ; Honoré C; Fairweather M; Cannell A; Jakob J; Haas RL; Szacht M; Fiore M; Casali PG; Pollock RE; Raut CP; Gronchi A; Swallow CJ
    Cancer; 2017 Jun; 123(11):1971-1978. PubMed ID: 28152173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence and survival analysis of resected soft tissue sarcomas of pelvic retroperitoneal structures.
    Doepker MP; Hanna KH; Thompson ZJ; Binitie OT; Letson DG; Gonzalez RJ
    J Surg Oncol; 2016 Jan; 113(1):103-7. PubMed ID: 26744131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent retroperitoneal sarcomas: Clinical outcomes of surgical treatment and prognostic factors.
    Tropea S; Mocellin S; Damiani GB; Stramare R; Aliberti C; Del Fiore P; Rossi CR; Rastrelli M
    Eur J Surg Oncol; 2021 May; 47(5):1201-1206. PubMed ID: 32950313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A contemporary large single-institution evaluation of resected retroperitoneal sarcoma.
    Bremjit PJ; Jones RL; Chai X; Kane G; Rodler ET; Loggers ET; Pollack SM; Pillarisetty VG; Mann GN
    Ann Surg Oncol; 2014 Jul; 21(7):2150-8. PubMed ID: 24615180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity modulated radiation therapy and surgery for Management of Retroperitoneal Sarcomas: a single-institution experience.
    Cosper PF; Olsen J; DeWees T; Van Tine BA; Hawkins W; Michalski J; Zoberi I
    Radiat Oncol; 2017 Dec; 12(1):198. PubMed ID: 29216884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG.
    Raut CP; Callegaro D; Miceli R; Barretta F; Rutkowski P; Blay JY; Lahat G; Strauss DC; Gonzalez R; Ahuja N; Grignani G; Quagliuolo V; Stoeckle E; De Paoli A; Pillarisetty VG; Nessim C; Swallow CJ; Bagaria S; Canter R; Mullen J; Gelderblom HJ; Pennacchioli E; van Coevorden F; Cardona K; Fiore M; Fairweather M; Gronchi A
    Clin Cancer Res; 2019 Apr; 25(8):2664-2671. PubMed ID: 30723141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant radiotherapy in retroperitoneal sarcomas. A Scandinavian Sarcoma Group study of 97 patients.
    Trovik LH; Ovrebo K; Almquist M; Haugland HK; Rissler P; Eide J; Engellau J; Monge OR; Nyhus AB; Elde IK; Jebsen NL
    Acta Oncol; 2014 Sep; 53(9):1165-72. PubMed ID: 25000415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Operative management of primary retroperitoneal sarcomas: a reappraisal of an institutional experience.
    Hassan I; Park SZ; Donohue JH; Nagorney DM; Kay PA; Nasciemento AG; Schleck CD; Ilstrup DM
    Ann Surg; 2004 Feb; 239(2):244-50. PubMed ID: 14745333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic factors of retroperitoneal soft tissue sarcomas: analysis of 132 cases.
    Chen CQ; Yin L; Peng CH; Cai Y; Li YF; Zhao R; Zhou HJ; Li HW
    Chin Med J (Engl); 2007 Jun; 120(12):1047-50. PubMed ID: 17637220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of histology on survival in retroperitoneal sarcomas.
    Brown RE; St Hill CR; Greene QJ; Farmer RW; Reuter NP; Callendar GG; Martin RC; McMasters KM; Scoggins CR
    Am J Surg; 2011 Dec; 202(6):748-52; discussion 752-3. PubMed ID: 22030405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors for reoperation of recurrent retroperitoneal sarcoma: The role of clinicopathological factors other than histologic grade.
    Yang JY; Kong SH; Ahn HS; Lee HJ; Jeong SY; Ha J; Yang HK; Park KJ; Lee KU; Choe KJ
    J Surg Oncol; 2015 Feb; 111(2):165-72. PubMed ID: 25244418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment at low-volume hospitals is associated with reduced short-term and long-term outcomes for patients with retroperitoneal sarcoma.
    Keung EZ; Chiang YJ; Cormier JN; Torres KE; Hunt KK; Feig BW; Roland CL
    Cancer; 2018 Dec; 124(23):4495-4503. PubMed ID: 30317543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the Use of Adjuvant Chemotherapy for High-Grade Truncal and Extremity Soft Tissue Sarcomas.
    Squires MH; Ethun CG; Suarez-Kelly LP; Yu PY; Hughes TM; Shelby RD; Tran TB; Poultsides G; Charlson J; Gamblin TC; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick BA; Fields RC; Pollock RE; Grignol V; Cardona K; Howard JH
    J Surg Res; 2020 Jan; 245():577-586. PubMed ID: 31494391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors in primary retroperitoneal soft-tissue sarcomas.
    Bevilacqua RG; Rogatko A; Hajdu SI; Brennan MF
    Arch Surg; 1991 Mar; 126(3):328-34. PubMed ID: 1998475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retroperitoneal sarcomas: patterns of care at diagnosis, prognostic factors and focus on main histological subtypes: a multicenter analysis of the French Sarcoma Group.
    Toulmonde M; Bonvalot S; Méeus P; Stoeckle E; Riou O; Isambert N; Bompas E; Jafari M; Delcambre-Lair C; Saada E; Le Cesne A; Le Péchoux C; Blay JY; Piperno-Neumann S; Chevreau C; Bay JO; Brouste V; Terrier P; Ranchère-Vince D; Neuville A; Italiano A;
    Ann Oncol; 2014 Mar; 25(3):735-742. PubMed ID: 24567518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.